91ÉçÇø

Jas Singh

Academic title(s): 

Assistant Professor

Jas Singh
Division: 
Urology
Degree(s): 
  • MD, FRCSC
  • Bachelor of Science (BSc)
  • Bachelor of Science in Medicine (BSc Med)
  • Doctor of Medicine (MD)
  • Fellow of the Royal College of Surgeons of Canada (FRCSC)
Location: 
91ÉçÇø Health Centre (MUHC - Glen) - Royal Victoria Hospital
Jewish General Hospital
LaSalle Hospital
Current research: 
  • Outcomes in robotic and minimally invasive surgery for benign prostatic hyperplasia
  • Applications and outcomes in hyperbaric oxygen therapy
  • Novel agents and treatments for urinary tract fibrosis
Clinical Interests: 
  • Upper and lower urinary tract reconstruction
  • Complex abdominal and bladder reconstruction
  • Voiding dysfunction and incontinence
  • Neuromodulation
  • Urethral reconstruction
  • Robotic benign and reconstructive surgery
Biography: 

Dr. Singh was born and raised in Winnipeg, Canada where he completed a bachelor of science degree in biochemistry at The University of Winnipeg. He then completed medical school and urology residency training at the University of Manitoba. Following royal college certification, he completed further subspeciality specialization in functional and reconstructive urology at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Dr. Singh specializes in complex urinary tract reconstruction including genitourinary cancer survivor patients suffering from the devastating urinary tract complications following radiation therapy or radical surgery.

Selected publications: 

[1] Singh J, Roubaud MS, Smith III TG, Westney OL. Options for Surgical Reconstruction of the Heavily Irradiated Pelvis. In Female Genitourinary and Pelvic Floor Reconstruction. Edited by FE Martins, HV Holm, J Sandhu and K McCammon. Springer Nature. In Press.

[2] Singh J, Cunningham KG, Karam JA. Chapter 19 – Management of Urologic Complications in Gynecologic Oncology Surgery. In Principles of Gynecologic Oncology Surgery 2nd Edition. Edited by PT Ramirez and M Frumovitz. Elsevier. In Press.

[3] Singh J, Smith TG III, Westney OL. Artificial Urinary Sphincter Considerations in Men With Prior Inflatable Penile Prosthesis Placement. J Sex Med. 2022 Oct;19(10):1495-8.

[4] Singh J. Re: Marc Sbizzera, Nicolas Morel-Journal, Alain Ruffion, et al. Rectourethral Fistula Induced by Localised Prostate Cancer Treatment: Surgical and Functional Outcomes of Transperineal Repair with Gracilis Muscle Flap Interposition. Eur Urol. 2022; 81:305-12. Eur Urol. 2022 Mar;81(3): e66-e67.

[5] Singh J. Verteporfin: A Novel Antiproliferative Agent for Urinary Tract Fibrosis? Société Internationale d’Urologie Journal. 2022;3(1):41-3.

[6] Singh J. Urethrocutaneous fistula repair following hypospadias surgery using the PATIO technique for small fistulae: A single centre experience. J Pediatr Urol. 2021 Dec 1: S1477-5131(21)00570-2.

[7] Singh J, Smith III TG, Westney OL. Management of Ureterovaginal and Vesicovaginal Fistula after Abdominal and Pelvic Surgery. American Urological Association Update Series. 2021;40.

[8] Singh J, Smith III TG, Westney OL. Images – Urinary tract reconstruction following ureteral coil embolization for ureterovaginal fistula in a young female patient. Can Urol Assoc J.2022;16(1): E54-6.

[9] Singh J, Smith III TG. Consults and Emergencies: Upper Tract Obstruction. American Urological Association Urology Core Curriculum. AUA University. 2022.

[10] Singh J, Smith III TG. Consults and Emergencies: Upper Urinary Tract and Retroperitoneal Hemorrhage. American Urological Association Urology Core Curriculum. AUA University 2022.

[11] Singh J, Smith III TG. Consults and Emergencies: Hematuria. American Urological Association Urology Core Curriculum. AUA University. 2022.

[12] Singh J, Wong R, Bansal RK. Images - pT3a clear-cell renal cell carcinoma in a renal allograft managed effectively with open partial nephrectomy. Can Urol Assoc J. 2019 Feb 26;13(11): E385-E386.

[13] Singh J. Primary localized amyloidosis causing urethral stricture disease: a mimicker of urothelial carcinoma. J Surg Case Rep. 2021 May 27;2021(5): rjab201.

[14] Ren R, Koti M, Hamilton T, Graham CH, Nayak JG, Singh J, Drachenberg DE, Siemens DR. A primer on tumour immunology and prostate cancer immunotherapy. Can Urol Assoc J. 2016 Jan;10(1-2):60-5.

[15] Singh J, Politis A, Loucks L, Hedden DR, Bohm ER. Trends in revision hip and knee arthroplasty observations after implementation of a regional joint replacement registry. Can J Surg. 2016 Sep;59(5):304-10.

Follow us on:

Back to top